Cargando…
TOMM40‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s disease
The translocase of outer mitochondrial membrane 40 (TOMM40) ‘523’ polymorphism has previously been associated with age of Alzheimer’s disease onset and cognitive functioning in non-pathological ageing, but has not been explored as a candidate risk marker for cognitive decline in Parkinson’s disease...
Autores principales: | Bakeberg, Megan C., Gorecki, Anastazja M., Pfaff, Abigail L., Hoes, Madison E., Kõks, Sulev, Akkari, P. Anthony, Mastaglia, Frank L., Anderton, Ryan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263775/ https://www.ncbi.nlm.nih.gov/pubmed/34234128 http://dx.doi.org/10.1038/s41531-021-00200-y |
Ejemplares similares
-
The TOMM40 ‘523’ polymorphism in disease risk and age of symptom onset in two independent cohorts of Parkinson’s disease
por: Bakeberg, Megan C., et al.
Publicado: (2021) -
Single Nucleotide Polymorphisms Associated With Gut Homeostasis Influence Risk and Age-at-Onset of Parkinson's Disease
por: Gorecki, Anastazja M., et al.
Publicado: (2020) -
Use of local genetic ancestry to assess TOMM40-523′ and risk for Alzheimer disease
por: Bussies, Parker L., et al.
Publicado: (2020) -
APOE ε4-TOMM40 ‘523 haplotypes and the risk of Alzheimer’s disease in older Caucasian and African Americans
por: Yu, Lei, et al.
Publicado: (2017) -
TOMM40 ‘523 Genotype Distinguishes Patterns of Cognitive Improvement for Executive Function in APOE
ɛ3 Homozygotes
por: Watts, Amber, et al.
Publicado: (2023)